Le Lézard
Classified in: Health
Subjects: PDT, FDA

Mediso receives FDA approval for InterViewtm nuclear medicine image processing software


BUDAPEST, Hungary, June 21, 2023 /PRNewswire/ -- Mediso has announced the Food and Drug Administration (FDA) clearance of the InterViewtm FUSION and InterViewtm XP multimodality (PET/SPECT/MRI/CT) image processing and reporting software which is specifically adapted for nuclear medicine and molecular imaging workflows.

 

Mediso

 

The vendor independent InterViewtm software offers a complete solution for image visualization, post-processing and reporting specifically adapted for the routine nuclear medicine and molecular imaging workflow. Workflows and specialized tools cover the most common nuclear medicine studies including bone, cardiac, central nervous system, thyroid, parathyroid, kidney, liver, digestive system and lung. Fast and standardized reporting is available for all nuclear medicine procedures. The software improves SPECT image quality with iterative reconstruction and reach absolute quantitation with Tera-Tomotm SPECT reconstruction engine, making fast and accurate personalized dosimetry possible. It also features a variety of state-of-the-art modules to enhance clinical and preclinical research work such as automatic lesion detection, and automatic segmentation and image denoising. The InterViewtm software seamlessly integrates to any hospital information system either running on stand-alone workstation, or on physical or virtualized server.

"Receiving the FDA nod for our image processing software marks the next step in marketing our clinical products in the USA," said Istvan Bagamery, founder and CEO of Mediso. "The InterViewtm software together with the AnyScan SPECT and SPECT/CT clinical systems provide a complete solution for all nuclear medicine routine and research application and they demonstrate our continuous commitment to the molecular imaging market."

Mediso, works in the field of medical imaging for 30+ years with a profile of development, manufacturing, selling and servicing standalone and multi-modality imaging devices. The company offers complete solutions from hardware design to evaluation and quantification software for clinical patient care and preclinical research.

Mediso has a leader position in the clinical nuclear medicine market with over 1500 commissioned systems around the world. Beyond the market leading AnyScan TRIO SPECT/CT, Mediso also offers an integrated SPECT/PET/CT triple modality system that is unique on the market.

Products are sold directly or through a distribution network in 100+ countries worldwide.

Logo - https://mma.prnewswire.com/media/2077004/4035811/Mediso_Logo.jpg


These press releases may also interest you

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...

at 11:15
"My husband uses supplemental oxygen, and he needed a way to prevent continual kinks in the line," said an inventor, from Greenville, S.C., "so I invented the No Kink. My design helps provide continuous air flow, and it could also help prevent...

at 11:00
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has experienced a year of achievements across its three Centres of Excellence?Oncology, Genomics, and Transplantation. KFSH&RC's Oncology Centre of Excellence continues to lead the fight...

at 11:00
"I wanted to create a new type of mosquito repellant that can be worn on any area of the body to deter bites and irritation," said an inventor, from Waterbury, Conn., "so I invented the BYE BYE. My design enables you to enjoy a backyard party,...



News published on and distributed by: